The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

Dubai police foil robbery worth AED660K
Saqr Ghobash to lead FNC delegation to Azerbaijan
Dubai Police handles 713,000 non-emergency calls in 2024
H.H. Sheikh Mohammed unveils Dubai Museum of Art
Dubai Police launch 'Fit Zone 2025' to support inmates' health
Abu Dhabi to host global pledging event for polio eradication
H.H. Sheikh Hamdan congratulates Dubai's first Student Council
Abu Dhabi Crown Prince to lead UAE delegation at APEC Summit
